566 filings
Page 9 of 29
6-K
gse62bsfjnnapun9e
7 May 18
Condensed Interim Consolidated Financial Statements
4:02pm
6-K
8uy02qquyv0pywx
1 May 18
Current report (foreign)
5:10pm
6-K
f4t02p0e p83
9 Apr 18
Current report (foreign)
12:00am
6-K
1phim4n
9 Apr 18
Annual and Special Meeting of Shareholders
12:00am
6-K
yth npdffo5rnu
28 Mar 18
Current report (foreign)
12:00am
6-K
43qbtpyqxanjdys t1o
28 Mar 18
Current report (foreign)
12:00am
6-K
h15z50 yzk91svgtdxq
28 Mar 18
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results
12:00am
6-K
nuse5deh436n3 nayfer
21 Mar 18
Aeterna Zentaris to Announce Fourth Quarter and Year End 2017 Financial and Operating Results on March 28th, 2018
12:00am
6-K
crvegnirno 57naoj6in
6 Mar 18
Current report (foreign)
12:00am
6-K
n4g2n9y
5 Mar 18
Aeterna Zentaris Appoints James Clavijo as Chief Financial Officer
12:00am
6-K
bpth68uv
5 Mar 18
Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit
12:00am
6-K
r8110
26 Feb 18
Current report (foreign)
12:00am
6-K
wss9rijt
19 Jan 18
Current report (foreign)
12:00am
6-K
tzxeiun
17 Jan 18
Aeterna Zentaris Enters into Licensing and Assignment Agreement with Strongbridge for Macrilen™ (macimorelin) in the U.S. and Canada
12:00am
6-K
hrmhima f2u3fumvlh2
26 Dec 17
Current report (foreign)
12:00am
6-K
grj ykhlxjg76u4fnf
22 Dec 17
Aeterna Zentaris Provides Update on Litigation against David Dodd and Philip Theodore
12:00am
6-K
grfub z6e
21 Dec 17
Aeterna Zentaris Announces FDA Approval of Macrilen™ (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency
12:00am
6-K
etd4mr5njit5zl96ucej
8 Dec 17
Aeterna Zentaris Announces Departure of Interim Chief Financial Officer
12:00am
6-K
y0umd9
28 Nov 17
Current report (foreign)
12:00am
6-K
ne7k4n2c0l a1uws
8 Nov 17
Condensed Interim Consolidated Financial Statements
12:00am